With Pfizer, Moderna and Sputnik V shots being widely distributed since December, US pharma giant Merck and its partner Institut Pasteur in France have canceled their coronavirus vaccine projects due to low immune responses.
Merck, known as MSD outside North America, said on Monday that it was discontinuing the development of two of its vaccine candidates.
Continue reading https://on.rt.com/b09k